Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000800278 | SCV000939983 | pathogenic | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu4*) in the TYMP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYMP are known to be pathogenic (PMID: 9924029, 15781193). This variant is present in population databases (rs764792655, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TYMP-related conditions. ClinVar contains an entry for this variant (Variation ID: 646061). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002501066 | SCV002809732 | pathogenic | Mitochondrial DNA depletion syndrome 1 | 2021-07-09 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002501066 | SCV003816055 | likely pathogenic | Mitochondrial DNA depletion syndrome 1 | 2022-03-31 | criteria provided, single submitter | clinical testing |